Regeneron Pharmaceuticals Inc 2022 Sustainability Report
Company: Regeneron Pharmaceuticals Inc
Sector: Manufacturing
Country: United States
Year: 2022
Type: Sustainability Report
Pages: 82
The report describes Regeneron's 2022 growth, including approximately 35 investigational medicines in clinical development and a year-end workforce of 11,851 employees. Environmental progress included 20% renewable electricity, 100% of waste diverted from landfill and a 14% reduction in combined market-based Scope 1 and 2 GHG emissions per square meter against the 2016 peak baseline. The company also reported $18.7 million in nonprofit giving. Employee community engagement included 6,735 volunteers contributing 31,200 hours.
Reporting standards, commitments and assurance details are available with a free account.
Data Services
From bulk PDFs to structured indicators and machine-readable documents.